March 9, 2011

Dolutegravir, Trii and new abacavir data- How it all ties together

By Nelson Vergel Powerusa.org Dr Joe Eron presented new dosing and efficacy phase 2b data on the new GSK integrase inhibitor dolutegravir (DTG, S/GSK1349572) using 50 […]
March 8, 2011

Fw: Hot Topics at The Body’s “Ask the Experts” Forums

From: “News at The Body” <update@news.thebody.com> Date: 08 Mar 2011 13:08:08 -0500 To: <powertx@aol.com> ReplyTo: “News at The Body” <update@news.thebody.com> Subject: Hot Topics at The Body’s […]
March 6, 2011

The Long-Term Survivor Dilemma

From http://www.thebody.com/content/art60472.html?ts=pf By Nelson Vergel February 14, 2011 “Nelson, what am I going to do?” This sentence is part of a conversation that I seem to […]
March 6, 2011

Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?

Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? By Nelson Vergel March 2, 2011 Jay Lalezari, M.D., from the University of California-San […]